(Q37973712)

26 August 2017

0 references

The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies (English)

1 reference

26 August 2017

0 references

1 reference

András Komócsi

1

1 reference

26 August 2017

András Vorobcsuk

2

1 reference

26 August 2017

Réka Faludi

3

1 reference

26 August 2017

Tünde Pintér

4

1 reference

26 August 2017

Zsófia Lenkey

5

1 reference

26 August 2017

Gyöngyvér Költo

6

1 reference

26 August 2017

László Czirják

7

1 reference

26 August 2017

language of work or name

1 reference

5 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

51

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

1027-1036

1 reference

Survival and causes of death in 366 Hungarian patients with systemic sclerosis.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Mortality in systemic sclerosis: an international meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Systemic sclerosis: an update in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Mortality and causes of death in a Swedish series of systemic sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

21 January 2018

Scleroderma epidemiology

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Clinical and genetic factors predictive of mortality in early systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Determinants of morbidity and mortality of systemic sclerosis in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Long-term outcomes of scleroderma renal crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Coronary angiographic findings in asymptomatic systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Primary myocardial involvement in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

21 January 2018

Scleroderma and survival

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

The prognostic factors of systemic sclerosis for survival among Koreans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER357

10.1093/RHEUMATOLOGY/KER357

21 January 2018

Identifiers

DOI

1 reference

release_75mogh7v2zdo5p5rg6z5jzmsuy

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/75mogh7v2zdo5p5rg6z5jzmsuy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference